We are monitoring the impact of COVID-19 on Latin America PEGylated Proteins Market Get in touch with us for detailed analysis Know More
Share on

Latin America PEGylated Proteins Market Research Report - Segmented By Protein Type, Application, Consumables, End User & Country (Mexico, Brazil, Argentina, Chile & Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3227
Pages: 135

Latin America Pegylated Proteins Market Size & Growth (2022 to 2027):

As per the research report, the size of the Latin America PEGylated Proteins Market is valued at USD 112.02 million in 2022 and estimated to be growing at a CAGR of 11.90%, to reach USD 196.54 million by 2027 during the forecast period 2022 to 2027.

The major market drivers in Latin America have increased pharmaceutical and biotechnology R&D spending, growth in the biologics sector, high prevalence of lifestyle diseases, rising adoption of protein-based drugs over non-protein-based drugs, and increased protein stability and circulating half-life through pegylation.

According to statistics, the PEGylated proteins market is predicted to grow at a CAGR of 10.5 percent, from USD 690.6 million in 2016 to USD 137.8 million in 2021.

Increased R&D spending by pharmaceutical & biotechnology businesses, rise in the biologics industry, high prevalence of lifestyle illness, and increased attention on techniques to improve protein stability and circulation half-life are some of the primary regional drivers for the market.

Another important factor is the growing prospects in emerging markets and top-selling biologics pharmaceuticals that will soon be off-patent, resulting in growth for Latin America in this sector.

The escalating incidence of chronic illnesses such as cancer, kidney disease, and rheumatoid arthritis is driving market expansion. On the basis of study of the Centers for Disease Control & Prevention - Chronic Renal Disease in Mexico, chronic kidney disease affects 15% of American adults or 5 million people.

On the other hand, rising PEGylation process costs and the patent expiration of certain medications are expected to stifle market growth. However, the market's most significant negatives are drug failure and recall.

The government should maintain guidelines for pharmaceutical companies to deliver effective treatments at low prices accessible to the poor.

This research report on the Latin America Pegylated Proteins Market has been segmented and sub-segmented into the following categories:

By Protein Type:

  • Interferons
  • Erythropoietin
  • MAbs

By Application:

  • Chronic Kidney Diseases
  • Cancer Treatment

By Consumables:

  • Reagents
  • PEGylation Kits

By End-User:

  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Academic Research Institutes

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, the Latin America Pegylated Proteins Market has a moderate share. However, increasing adoption of biologics drugs such as MABs, erythropoietin, & interferon to treat chronic diseases, increased government funding & grants for research activities, and increased R&D spending for drug discovery early stages contribute to this the market's growth.

The Brazil Pegylated Proteins Market is expected to grow significantly in the following years, owing to rising demand for PEGylation, an increase in the number of chronic diseases, and the presence of promising pipeline medications. In addition, PEGylated molecules also have various advantages, such as a longer half-life, decreased toxicity, lower immunogenicity, and increased proteolytic protection, all of which contribute to the market's growth.

The Mexico Pegylated Proteins Market has significant growth in this region due to the development of new therapies based on PEGylated proteins for the treatment of chronic renal disease is becoming increasingly important. Furthermore, biotechnology and pharmaceutical businesses are increasing their spending on inventions programs, encouraging regional market growth.

Furthermore, the growing elderly population and the high prevalence of chronic diseases will propel the market forward. It is expected that the number of population aged 65 and up in the United States is estimated to nearly double by 2060, from 52 million in 2018 to 95 million. As a result, the aged population is increasingly susceptible to chronic diseases, driving up the need for sophisticated diagnostics and treatment plans.

Beneficial government initiatives & rise in the number of partnerships are the two geographical aspects that are predicted to influence growth.

KEY MARKET PLAYERS

Prominent companies leading in the Latin America PEGylated Proteins Market profiled in the report are Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH, Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.

1.Introduction           

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                

2. Research Methodology                    

                2.1 Introduction        

                2.2 Research Phases                      

         2.2.1 Secondary Research           

         2.2.2 Primary Research 

         2.2.3 Econometric Modelling      

         2.2.4 Expert Validation  

                2.3 Analysis Design  

                2.4 Study Timeline   

3. Overview                

                3.1 Executive Summary                

                3.2 Key Inferences  

                3.3 Epidemology       

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)             

                4.1 Market Drivers   

                4.2 Market Restraints                    

                4.3 Key Challenges  

                4.4 Current Opportunities in the Market       

5. Market Segmentation

                5.1 Protein Type       

         5.1.1 Introduction           

         5.1.2 Interferons             

         5.1.3 Erythropoietin       

         5.1.4 mAbs         

         5.1.5  Y-o-Y Growth Analysis, By Protein Type    

         5.1.6  Market Attractiveness Analysis, By Protein Type  

         5.1.7  Market Share Analysis, By Protein Type    

                5.2 Consumables      

         5.2.1 Introduction           

         5.2.2 Reagents 

         5.2.3 PEGylation Kits      

         5.2.4 Y-o-Y Growth Analysis, By Consumables    

         5.2.5 Market Attractiveness Analysis, By Consumables  

         5.2.6 Market Share Analysis, By Consumables    

                5.3 Application                 

         5.3.1 Introduction           

         5.3.2 Chronic Kidney Diseases   

         5.3.3 Cancer Treatment

         5.3.4 Y-o-Y Growth Analysis, By Application         

         5.3.5  Market Attractiveness Analysis, By Application      

         5.3.6  Market Share Analysis, By Application       

                5.4 End-Users                   

         5.4.1 Introduction           

         5.4.2 Pharmaceuticals & Biotechnology Companies         

         5.4.3 CROs          

         5.4.4 Academic Research Institutes         

         5.4.5 Y-o-Y Growth Analysis, By End-Users          

         5.4.6  Market Attractiveness Analysis, By End-Users       

         5.4.7  Market Share Analysis, By End-Users         

6. Geographical Analysis

                6.1 Introduction        

         6.1.1 Regional Trends    

         6.1.2 Impact Analysis     

         6.1.3 Y-o-Y Growth Analysis        

  6.1.3.1 By Geographical Area

  6.1.3.2 By Protein Type

  6.1.3.3 By Consumables

  6.1.3.4 By Application

  6.1.3.5 By End-Users

         6.1.4  Market Attractiveness Analysis     

  6.1.4.1 By Geographical Area

  6.1.4.2 By Protein Type

  6.1.4.3 By Consumables

  6.1.4.4 By Application

  6.1.4.5 By End-Users

         6.1.5  Market Share Analysis      

  6.1.5.1 By Geographical Area

  6.1.5.2 By Protein Type

  6.1.5.3 By Consumables

  6.1.5.4 By Application

  6.1.5.5 By End-Users

                6.2 Brazil      

                6.3 Mexico  

                6.4 Rest of Latin America      

7.Strategic Analysis                 

                7.1 PESTLE analysis  

         7.1.1 Political     

         7.1.2 Economic 

         7.1.3 Social         

         7.1.4 Technological         

         7.1.5 Legal          

         7.1.6 Environmental       

                7.2 Porter’s Five analysis       

         7.2.1 Bargaining Power of Suppliers        

         7.2.2 Bargaining Power of Consumers    

         7.2.3 Threat of New Entrants     

         7.2.4 Threat of Substitute Products and Services              

         7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                  

                8.1 Laysan Bio Ltd.   

         8.1.1 Overview 

         8.1.2 Product Analysis   

         8.1.3 Financial analysis  

         8.1.4 Recent Developments       

         8.1.5 SWOT analysis       

         8.1.6 Analyst View          

                8.2 Iris Biotech GmbH                    

                8.3 Biomatrik Inc.     

                8.4 Quanta BioDesign Ltd.    

                8.5 Cealares GmbH  

                8.6 Creative PEGworks                 

                8.7 Jenkem Technology USA Inc.       

                8.8 NOF Corporation                      

                8.9 Thermo Fisher Scientific Inc.        

                8.10 Merck Millipore                      

9.Competitive Landscape                     

                9.1 Market share analysis     

                9.2 Merger and Acquisition Analysis

                9.3 Agreements, collaborations and Joint Ventures  

                9.4 New Product Launches  

10.Market Outlook and Investment Opportunities                   

Appendix                    

                a) List of Tables                

                b) List of Figures       

  1. Latin America PEGylated Proteins Market By Protein Type, From 2022 to 2027 ( USD Million )
  2. Latin America Interferons Market By Region, From 2022 to 2027 ( USD Million )
  3. Latin America Erythropoietin Market By Region, From 2022 to 2027 ( USD Million )
  4. Latin America mAbs Market By Region, From 2022 to 2027 ( USD Million )
  5. Latin America PEGylated Proteins Market By End-User, From 2022 to 2027 ( USD Million )
  6. Latin America Pharmaceuticals & Biotechnology Companies Market By Region, From 2022 to 2027 ( USD Million )
  7. Latin America CROs Market By Region, From 2022 to 2027 ( USD Million )
  8. Latin America Academic Research Institutes Market By Region, From 2022 to 2027 ( USD Million )
  9. Latin America PEGylated Proteins Market By Application, From 2022 to 2027 ( USD Million )
  10. Latin America Chronic Kidney Disease Market By Region, From 2022 to 2027 ( USD Million )
  11. Latin America Cancer Treatment Market By Region, From 2022 to 2027 ( USD Million )
  12. Latin America PEGylated Proteins Market By Consumables, From 2022 to 2027 ( USD Million )
  13. Latin America Reagents Market By Region, From 2022 to 2027 ( USD Million )
  14. Latin America PEGylation Kits Market By Region, From 2022 to 2027 ( USD Million )
  15. Brazil PEGylated Proteins Market By Protein Type, From 2022 to 2027 ( USD Million )
  16. Brazil PEGylated Proteins Market By End-User, From 2022 to 2027 ( USD Million )
  17. Brazil PEGylated Proteins Market By Application, From 2022 to 2027 ( USD Million )
  18. Brazil PEGylated Proteins Market By Consumables, From 2022 to 2027 ( USD Million )
  19. Argentina PEGylated Proteins Market By Protein Type, From 2022 to 2027 ( USD Million )
  20. Argentina PEGylated Proteins Market By End-User, From 2022 to 2027 ( USD Million )
  21. Argentina PEGylated Proteins Market By Application, From 2022 to 2027 ( USD Million )
  22. Argentina PEGylated Proteins Market By Consumables, From 2022 to 2027 ( USD Million )
  23. Mexico PEGylated Proteins Market By Protein Type, From 2022 to 2027 ( USD Million )
  24. Mexico PEGylated Proteins Market By End-User, From 2022 to 2027 ( USD Million )
  25. Mexico PEGylated Proteins Market By Application, From 2022 to 2027 ( USD Million )
  26. Mexico PEGylated Proteins Market By Consumables, From 2022 to 2027 ( USD Million )
  27. Rest of Latin America PEGylated Proteins Market By Protein Type, From 2022 to 2027 ( USD Million )
  28. Rest of Latin America PEGylated Proteins Market By End-User, From 2022 to 2027 ( USD Million )
  29. Rest of Latin America PEGylated Proteins Market By Application, From 2022 to 2027 ( USD Million )
  30. Rest of Latin America PEGylated Proteins Market By Consumables, From 2022 to 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample